Want to track MBX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
MBX Biosciences, Inc. (MBX) Statistics
Valuation metrics
Market Cap 1.9B
Enterprise value 2.07B
Trailing P/E (ttm) -28.6
Forward P/E -
PEG ratio 25.47
Price/Sales (ttm) -
Price/Book (mrq) 6.69
Enterprise Value/Revenue -
Enterprise Value/EBITDA -23.95
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 1.14M
Average volume (90 days) 867.88K
Price summary
52-Week low 9.63
52-Week high 66.55
Beta -
50-Day moving average 47.94
200-Day moving average 34.66
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.19%
Return on equity -0.25%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.86
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 9.45
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 30.79%
Book value per share (mrq) 9.4
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
